Industry Growth Insights published a new data on “Oral Controlled Drug Delivery System Market”. The research report is titled “Oral Controlled Drug Delivery System Market research by Types (Diffusion Controlled Release System, Dissolution Controlled Release System, Ion Exchange Resins Controlled Release, Hydro-dynamically Balanced Drug Delivery System, Osmotically Controlled Release System, Dissolution & Diffusion Controlled Release System), By Applications (Hospitals, Clinics, Other), By Players/Companies AstraZeneca Plc., Mylan N.V., Sanofi, F. Hoffman-La-Roche Ltd., Bristol-Myers Squibb Company, Sun Pharmaceuticals Industries Ltd, Abbott Laboratories, Merck & Co. Inc., Novartis AG, Pfizer Inc., Vectura Group plc., GlaxoSmithKline plc., Johnson & Johnson Services, Inc.”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Oral Controlled Drug Delivery System Market Research Report
By Type
Diffusion Controlled Release System, Dissolution Controlled Release System, Ion Exchange Resins Controlled Release, Hydro-dynamically Balanced Drug Delivery System, Osmotically Controlled Release System, Dissolution & Diffusion Controlled Release System
By Application
Hospitals, Clinics, Other
By Companies
AstraZeneca Plc., Mylan N.V., Sanofi, F. Hoffman-La-Roche Ltd., Bristol-Myers Squibb Company, Sun Pharmaceuticals Industries Ltd, Abbott Laboratories, Merck & Co. Inc., Novartis AG, Pfizer Inc., Vectura Group plc., GlaxoSmithKline plc., Johnson & Johnson Services, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Oral Controlled Drug Delivery System Market Report Segments:
The global Oral Controlled Drug Delivery System market is segmented on the basis of:
Types
Diffusion Controlled Release System, Dissolution Controlled Release System, Ion Exchange Resins Controlled Release, Hydro-dynamically Balanced Drug Delivery System, Osmotically Controlled Release System, Dissolution & Diffusion Controlled Release System
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AstraZeneca Plc.
- Mylan N.V.
- Sanofi
- F. Hoffman-La-Roche Ltd.
- Bristol-Myers Squibb Company
- Sun Pharmaceuticals Industries Ltd
- Abbott Laboratories
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Vectura Group plc.
- GlaxoSmithKline plc.
- Johnson & Johnson Services, Inc.
Highlights of The Oral Controlled Drug Delivery System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Diffusion Controlled Release System
- Dissolution Controlled Release System
- Ion Exchange Resins Controlled Release
- Hydro-dynamically Balanced Drug Delivery System
- Osmotically Controlled Release System
- Dissolution & Diffusion Controlled Release System
- By Application:
- Hospitals
- Clinics
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oral Controlled Drug Delivery System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
An oral controlled drug delivery system (OCDDS) is a device that helps patients take their medications by mouth. It can be a pill-dispensing machine, an app that tracks medication intake, or a liquid formulation in a dropper bottle.
Some of the major companies in the oral controlled drug delivery system market are AstraZeneca Plc., Mylan N.V., Sanofi, F. Hoffman-La-Roche Ltd., Bristol-Myers Squibb Company, Sun Pharmaceuticals Industries Ltd, Abbott Laboratories, Merck & Co. Inc., Novartis AG, Pfizer Inc., Vectura Group plc., GlaxoSmithKline plc., Johnson & Johnson Services, Inc..
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Oral Controlled Drug Delivery System Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Oral Controlled Drug Delivery System Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Oral Controlled Drug Delivery System Market - Supply Chain
4.5. Global Oral Controlled Drug Delivery System Market Forecast
4.5.1. Oral Controlled Drug Delivery System Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Oral Controlled Drug Delivery System Market Size (000 Units) and Y-o-Y Growth
4.5.3. Oral Controlled Drug Delivery System Market Absolute $ Opportunity
5. Global Oral Controlled Drug Delivery System Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Oral Controlled Drug Delivery System Market Size and Volume Forecast by Type
5.3.1. Diffusion Controlled Release System
5.3.2. Dissolution Controlled Release System
5.3.3. Ion Exchange Resins Controlled Release
5.3.4. Hydro-dynamically Balanced Drug Delivery System
5.3.5. Osmotically Controlled Release System
5.3.6. Dissolution & Diffusion Controlled Release System
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Oral Controlled Drug Delivery System Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Oral Controlled Drug Delivery System Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Oral Controlled Drug Delivery System Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Oral Controlled Drug Delivery System Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Oral Controlled Drug Delivery System Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Oral Controlled Drug Delivery System Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Oral Controlled Drug Delivery System Demand Share Forecast, 2019-2026
9. North America Oral Controlled Drug Delivery System Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Oral Controlled Drug Delivery System Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Oral Controlled Drug Delivery System Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Oral Controlled Drug Delivery System Market Size and Volume Forecast by Type
9.7.1. Diffusion Controlled Release System
9.7.2. Dissolution Controlled Release System
9.7.3. Ion Exchange Resins Controlled Release
9.7.4. Hydro-dynamically Balanced Drug Delivery System
9.7.5. Osmotically Controlled Release System
9.7.6. Dissolution & Diffusion Controlled Release System
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Oral Controlled Drug Delivery System Demand Share Forecast, 2019-2026
10. Latin America Oral Controlled Drug Delivery System Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Oral Controlled Drug Delivery System Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Oral Controlled Drug Delivery System Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Oral Controlled Drug Delivery System Market Size and Volume Forecast by Type
10.7.1. Diffusion Controlled Release System
10.7.2. Dissolution Controlled Release System
10.7.3. Ion Exchange Resins Controlled Release
10.7.4. Hydro-dynamically Balanced Drug Delivery System
10.7.5. Osmotically Controlled Release System
10.7.6. Dissolution & Diffusion Controlled Release System
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Oral Controlled Drug Delivery System Demand Share Forecast, 2019-2026
11. Europe Oral Controlled Drug Delivery System Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Oral Controlled Drug Delivery System Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Oral Controlled Drug Delivery System Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Oral Controlled Drug Delivery System Market Size and Volume Forecast by Type
11.7.1. Diffusion Controlled Release System
11.7.2. Dissolution Controlled Release Sysem
11.7.3. Ion Exchange Resins Controlled Release
11.7.4. Hydro-dynamically Balanced Drug Delivery System
11.7.5. Osmotically Controlled Release System
11.7.6. Dissolution & Diffusion Controlled Release System
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Oral Controlled Drug Delivery System Demand Share, 2019-2026
12. Asia Pacific Oral Controlled Drug Delivery System Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Oral Controlled Drug Delivery System Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Oral Controlled Drug Delivery System Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Oral Controlled Drug Delivery System Market Size and Volume Forecast by Type
12.7.1. Diffusion Controlled Release System
12.7.2. Dissolution Controlled Release System
12.7.3. Ion Exchange Resins Controlled Release
12.7.4. Hydro-dynamically Balanced Drug Delivery System
12.7.5. Osmotically Controlled Release System
12.7.6. Dissolution & Diffusion Controlled Release System
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Oral Controlled Drug Delivery System Demand Share, 2019-2026
13. Middle East & Africa Oral Controlled Drug Delivery System Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Oral Controlled Drug Delivery System Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Oral Controlled Drug Delivery System Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Oral Controlled Drug Delivery System Market Size and Volume Forecast by Type
13.7.1. Diffusion Controlled Release System
13.7.2. Dissolution Controlled Release System
13.7.3. Ion Exchange Resins Controlled Release
13.7.4. Hydro-dynamically Balanced Drug Delivery System
13.7.5. Osmotically Controlled Release System
13.7.6. Dissolution & Diffusion Controlled Release System
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Oral Controlled Drug Delivery System Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Oral Controlled Drug Delivery System Market: Market Share Analysis
14.2. Oral Controlled Drug Delivery System Distributors and Customers
14.3. Oral Controlled Drug Delivery System Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. AstraZeneca Plc.
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Mylan N.V.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Sanofi
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. F. Hoffman-La-Roche Ltd.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Bristol-Myers Squibb Company
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Sun Pharmaceuticals Industries Ltd
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Abbott Laboratories
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Merck & Co. Inc.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Novartis AG
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Pfizer Inc.
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Vectura Group plc.
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. GlaxoSmithKline plc.
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Johnson & Johnson Services, Inc.
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19.